Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 3,192 | 7,390 | 5,550 | 8,429 | 7,141 |
| Operating Income | -3,192 | -7,390 | -5,550 | -8,429 | -7,141 |
| Other Income | 548 | 157 | -490 | 141 | 1,325 |
| Pre-tax Income | -2,643 | -7,233 | -6,040 | -8,288 | -5,816 |
| Net Income Continuous | -2,643 | -7,233 | -6,040 | -8,288 | -5,816 |
| Net Income | $-2,643 | $-7,233 | $-6,040 | $-8,288 | $-5,816 |
| EPS Basic Total Ops | -0.02 | -0.09 | -0.07 | -0.10 | -0.06 |
| EPS Basic Continuous Ops | -0.02 | -0.09 | -0.07 | -0.10 | -0.07 |
| EPS Diluted Total Ops | -0.02 | -0.09 | -0.07 | -0.10 | -0.06 |
| EPS Diluted Continuous Ops | -0.02 | -0.09 | -0.07 | -0.10 | -0.07 |
| EPS Diluted Before Non-Recurring Items | -0.05 | -0.09 | -0.07 | -0.07 | -0.07 |
| EBITDA(a) | $-3,174 | $-7,371 | $-5,531 | $-8,412 | $-7,107 |